Ratings by BTIG (Kaveri Pohlman)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/19/2021 Arcus Biosciences RCUS Maintain Buy
(N/A)
 
 
  Details
11/15/2021 CytomX Therapeutics CTMX New Coverage Buy
(N/A)
7.02
(6.55)
-6.7% Details
11/10/2021 Mersana MRSN Maintain Buy
(N/A)
 
 
  Details
11/9/2021 Mersana MRSN Maintain Neutral
(N/A)
 
 
  Details
10/15/2021 G1 Therapeutics, Inc. GTHX New Coverage Buy
(N/A)
5.98
(12.48)
108.7% Details
10/14/2021 BioAtla Inc. BCAB New Coverage Buy
(N/A)
27.46
(24.33)
-11.4% Details
10/14/2021 Checkmate Pharmaceuticals CMPI New Coverage Buy
(N/A)
4.03
(3.60)
-10.67% Details
10/14/2021 Gritstone Oncology GRTS New Coverage Buy
(N/A)
9.20
(11.02)
19.78% Details
10/14/2021 MacroGenics MGNX New Coverage Buy
(N/A)
20.94
(17.71)
-15.43% Details
10/14/2021 Mersana MRSN New Coverage Buy
(N/A)
8.66
(6.67)
-22.98% Details
10/14/2021 Nuvation Bio Inc NUVB New Coverage Buy
(N/A)
9.50
(9.14)
-3.79% Details
10/14/2021 OncoSec Medical ONCS New Coverage Buy
(N/A)
1.90
(1.29)
-32.11% Details
10/14/2021 Replimune Group REPL New Coverage Buy
(N/A)
31.16
(28.46)
-8.66% Details
10/14/2021 Seagen SGEN New Coverage Neutral
(N/A)
167.86
(164.33)
-2.1% Details
10/14/2021 Xencor, Inc. XNCR New Coverage Buy
(N/A)
38.69
(35.85)
-7.34% Details
10/14/2021 Arcus Biosciences RCUS New Coverage Buy
(N/A)
31.38
(44.86)
42.96% Details
9/15/2021 Sonnet BioTherapeutics SONN New Coverage Buy
(N/A)
0.56
(0.57)
1.79% Details